Experimental Pill Nearly Doubles Survival in Pancreatic Cancer
A late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
Discover tailored wealth management advice for women to maximize their assets. Enhance your financial strategy now.
18,135 articlesA late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
As COMPUTEX 2026 approaches, investors wonder if will NVIDIA stock rise. This guide breaks down the event's potential...
The Nasdaq Composite kicks off June on a cautious note as oil spikes raise risk, while Nvidia powers the tech rally. ...
As AI enthusiasm cools, investors pivot to hard assets. New data show demand data center power rising faster than exp...
As HIVE Digital Technologies prepares to report Q4 results, the stock has surged more than 100% in May. Traders are w...
Nexa delivered an earnings snapshot that matters for 2026. This guide breaks down the numbers, what they mean for gui...
Two $2 trillion companies are anchoring Intel’s AI roadmap with a $5 billion NVIDIA investment and a multiyear Google...
A rocket-test explosion at Cape Canaveral spared critical launch-pad components, preserving a path back to flight for...
Bitwise CIO Matt Hougan frames crypto as a contrarian bet for institutional buyers, a view that comes as AI stocks su...
Grayscale launches HYPG, its Hyperliquid ETF, on Nasdaq, promising ultra-low fees and deep liquidity as traders seek ...
LoanCare announces a new private-label mortgage servicing platform designed to be embedded directly into lenders' dig...
Dogecoin slips again, but a niche on-chain model points to a long-term accumulation floor. As traders debate a possib...